BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22678150)

  • 21. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of hypertension in African Americans.
    Ferdinand KC; Armani AM
    Crit Pathw Cardiol; 2007 Jun; 6(2):67-71. PubMed ID: 17667868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive medications.
    Slagle MA
    South Med J; 2001 Nov; 94(11):1071-3. PubMed ID: 11780676
    [No Abstract]   [Full Text] [Related]  

  • 24. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
    Chobanian AV; Bakris GL; Black HR; Cushman WC; Green LA; Izzo JL; Jones DW; Materson BJ; Oparil S; Wright JT; Roccella EJ; ;
    JAMA; 2003 May; 289(19):2560-72. PubMed ID: 12748199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of hypertensive disease in black patients.
    Gibbs CR; Beevers DG; Lip GY
    QJM; 1999 Apr; 92(4):187-92. PubMed ID: 10396605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension Control in Adults With CKD in China: Baseline Results From the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).
    Yan Z; Wang Y; Li S; Wang J; Zhang L; Tan H; Li S; Yang L; Pei H; Zhang L; Wang Y; Duan J; Jiao S; Zhao M; Fu S;
    Am J Hypertens; 2018 Mar; 31(4):486-494. PubMed ID: 29304216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
    Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
    Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug utilization and blood pressure control in a population where antihypertensives are given free: effect of policy change.
    Adedapo AD; Sikuade O; Adeleke S; Okechukwu R
    Afr J Med Med Sci; 2012 Dec; 41(4):349-56. PubMed ID: 23672098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic Issues in treating hypertension in CKD.
    Sica DA
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):42-7. PubMed ID: 21224029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review: antihypertensive drug therapy in black patients.
    Brewster LM; van Montfrans GA; Kleijnen J
    Ann Intern Med; 2004 Oct; 141(8):614-27. PubMed ID: 15492341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
    Deedwania PC
    Cardiol Clin; 2005 May; 23(2):139-52. PubMed ID: 15694743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical-epidemological study of drugs used to treat arterial hypertension and associated comorbidities.
    Leon MM; Mitu F
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):488-94. PubMed ID: 24340535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 'Birmingham Hypertension Square' for the optimum choice of add-in drugs in the management of resistant hypertension.
    Lip GY; Beevers M; Beevers DG
    J Hum Hypertens; 1998 Nov; 12(11):761-3. PubMed ID: 9844947
    [No Abstract]   [Full Text] [Related]  

  • 35. Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease.
    Magvanjav O; Cooper-DeHoff RM; McDonough CW; Gong Y; Segal MS; Hogan WR; Johnson JA
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):91-101. PubMed ID: 30427124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 7th Brazilian Guideline of Arterial Hypertension: Chapter 7 - Pharmacological Treatment.
    Malachias MVB; Paulo César Veiga Jardim PCV; Almeida FA; Lima E; Feitosa GS
    Arq Bras Cardiol; 2016 Sep; 107(3 Suppl 3):35-43. PubMed ID: 27819386
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypertension Management in Transition: From CKD to ESRD.
    Valika A; Peixoto AJ
    Adv Chronic Kidney Dis; 2016 Jul; 23(4):255-61. PubMed ID: 27324679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roundtable Discussion: Blood pressure lowering by any means, or do specific medications make a difference?
    Moser M; Pickering TG; Weber MA
    J Clin Hypertens (Greenwich); 2001; 3(6):369-75. PubMed ID: 11951864
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypertension therapies compared. Are the new nevertheless better than the old?].
    MMW Fortschr Med; 2005 Mar; 147(12):6, 8. PubMed ID: 15832780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.